Hemolytic uremic syndrome: A case review

Journal of Neuroscience Nursing

Volumn 41, Issue 4, 2009, Pages 188-190

  Black, Emily R ^a  

^a ST MARY S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; CASE REPORT; EPILEPTIC STATE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTENSIVE CARE; METHODOLOGY; NURSING; NURSING DISCIPLINE; PATHOPHYSIOLOGY;

BARBITURATES; CRITICAL CARE; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPNOTICS AND SEDATIVES; SPECIALTIES, NURSING; STATUS EPILEPTICUS; YOUNG ADULT;

EID: 70349561090     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/JNN.0b013e3181aaaa5f     Document Type: Review

References (16)

1. Banatvala, N., Griffen, P. M., Greene, K. D., Barrett, T. J., Bibb, W. F., Green, J. H., et al. (2001). The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical and epidemiologic findings. Journal of Infectious Disease, 183, 1063-1070.
2. Boyce, T. G., Swerdlow, D. L., & Griffin, P. M. (1995). Escherichia coli O157:H7 and the hemolytic-uremic syndrome. New England Journal of Medicine, 333, 364-368.
3. Camp-Sorrell, D. (2008). Hemolytic uremic syndrome. Oncology Nursing Forum, 35, 593.
4. Centers for Disease Control and Prevention. (2007). Bacterial Foodborne and Diarrheal Disease National Case Surveillance. Annual report 2005. Bethesda, MD: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention.
5. Garg, A. X., Suri, R. S., Barrowman, N., Rehman, F., Matsell, D., & Rosas-Arellano, M. P. (2003). Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome. Journal of the American Medical Association, 290, 1360-1370.
6. Kaplan, B. S., Meyers, K. E., & Schulman, S. L. (1998). The pathogenesis and treatment of hemolytic uremic syndrome. Journal of the American Society of Nephrology, 9, 1126-1133.
7. National Institute of Diabetes and Digestive and Kidney Diseases. (2005). Hemolytic uremic syndrome (NIH Publication No. 06-4570). Bethesda, MD: U. S. Department of Health and Human Services.
8. Oakes, R. S., Siegler, R. L., McReynolds, M. A., Pysher, T., & Pavia, A. T. (2006). Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics, 117, 1656-1662.
9. Peacock, E., Jacob, V. W., & Fallone, S. M. (2001). Escherichia coli O157:H7: Etiology, clinical features, complications, and treatment. Nephrology Nursing Journal, 28 (5), 547-549.
10. Ray, P. E., & Liu, X. (2001). Pathogenesis of Shiga toxininduced hemolytic uremic syndrome. Pediatric Nephrology, 16, 823-839.
11. Remuzzi, G., Ruggenenti, P., Colledan, M., Gridelli, B., Bertani, A., Bettinaglio, P., et al. (2004). Hemolytic uremic syndrome: A fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. American Journal of Transplantation, 5 (5), 1146-1150.
12. Schmelzer, M., & Stam, M. A. (2000). A hidden menace: Hemolytic uremic syndrome. American Journal of Nursing, 100, 26-33.
13. Trachtman, H., & Christen, E. (1999). Pathogenesis, treatment and therapeutic trials in hemolytic uremic syndrome. Current Opinion in Pediatrics, 11, 162-168.
14. Tserenpuntsag, B., Chang, H. G., Smith, P. F., & Morse, D. L. (2005). Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerging Infectious Diseases, 11, 1955-1957.
15. Tzipori, S., Sheoran, A., Akiyoshi, D., Donohue-Rolfe, A., & Trachtman, H. (2004). Antibody therapy in the management of Shiga toxin-induced hemolytic uremic syndrome. Clinical Microbiology Reviews, 17, 926-941.
16. Zimmerhackl, L. B. (2000). E. coli, antibiotics, and the hemolytic uremic syndrome. New England Journal of Medicine, 342, 1990-1991.